| Aeg Rhode Island Professional, Pc | |
|
2 Dexter St, Pawtucket, RI 02860-2996 | |
| (401) 723-9540 | |
| (314) 741-4947 |
| Full Name | Aeg Rhode Island Professional, Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2 Dexter St, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730898263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Carl D Corrow |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1689681066 PECOS PAC ID: 0749265163 Enrollment ID: I20040621001070 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | John D Corrow |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1720095953 PECOS PAC ID: 8022077312 Enrollment ID: I20041004000248 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | Jonathan Kaplan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1023077898 PECOS PAC ID: 8628103579 Enrollment ID: I20100324000291 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | Scott W Sylvia |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1457316259 PECOS PAC ID: 8022024413 Enrollment ID: I20120206000866 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | Jared C Cox |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1417204801 PECOS PAC ID: 3678728144 Enrollment ID: I20180807000930 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | Monserrat Daniela Arias |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831714625 PECOS PAC ID: 3375969678 Enrollment ID: I20200818000597 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | Abdoulaye Wann |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1770152993 PECOS PAC ID: 3274939178 Enrollment ID: I20210901000101 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Provider Name | Chelsea Moran |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1942770888 PECOS PAC ID: 2264779446 Enrollment ID: I20221107001870 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aeg Rhode Island Professional, Pc 111 E 4th St Ste 440, Alton, IL 62002-6206 Ph: (618) 462-9818 | Aeg Rhode Island Professional, Pc 2 Dexter St, Pawtucket, RI 02860-2996 Ph: (401) 723-9540 |
News Archive
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
Celldex Therapeutics, Inc. today announced the presentation of promising clinical data on CDX-011 in metastatic melanoma at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Illinois. The Phase 2 study has met its primary endpoint and the results support additional studies in this indication.
Biodel Inc. announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.
Researchers at Albert Einstein College of Medicine of Yeshiva University have found that community-based pharmacies can be effective locations for offering rapid HIV testing, diagnosing HIV, and connecting those who test positive with medical care quickly. The study is in the August issue of the journal AIDS Patient Care and STDs.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
› Verified 7 days ago
Dr. Jonathan D Kaplan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2 Dexter St, Pawtucket, RI 02860 Phone: 401-723-9540 Fax: 401-725-6583 | |
Dr. Benjamin D Klibanoff, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 55 Broad St, Pawtucket, RI 02860 Phone: 401-723-3400 | |
Dr. Kenneth A Kaplan, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2 Dexter St, Pawtucket, RI 02860 Phone: 401-723-9540 Fax: 401-725-6583 | |
Glenn S. Prescod, M.d., M.p.h., Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 333 School St, Suite 301, Pawtucket, RI 02860 Phone: 401-725-3600 Fax: 401-728-8760 | |
Modern Eyes Llc Optometrist Medicare: Medicare Enrolled Practice Location: 145 Newport Ave, Pawtucket, RI 02861 Phone: 401-524-4025 | |
David Klibanoff, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 121 Broad St, Pawtucket, RI 02860 Phone: 401-723-3400 Fax: 401-727-2326 | |
Dr. Peter J Liberto, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 145 Newport Ave, Pawtucket, RI 02861 Phone: 401-729-0200 Fax: 401-729-0222 |